Search company, investor...

immco Diagnostics

About immco Diagnostics

Immco Diagnostics develops and distributes autoimmune disease diagnostics. It offers reference lab services to the US healthcare market. It is based in Williamsville, New York.

Headquarters Location

10 Earhart Drive Suite 100

Buffalo, New York, 14221,

United States

Missing: immco Diagnostics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: immco Diagnostics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing immco Diagnostics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

immco Diagnostics is included in 1 Expert Collection, including Medical Devices.


Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Latest immco Diagnostics News

Worldwide Autoimmune Disease Diagnostics Industry to 2026 - Increasing Epidemiology of Autoimmune Diseases is Driving Growth -

Aug 24, 2021

Trinity Biotech Group (Immco Diagnostics) The report will provide details about autoimmune disease diagnostics used in the treatment of autoimmune disease and how the market has been influenced by the pandemic of COVID-19. This report will also highlight the current and future market potential of autoimmune disease diagnostics with detailed analyses of the competitive environments between companies. Drivers, restraints, opportunities, pricing analysis, prevalence or incidence of autoimmune disease and regulatory scenarios will also be covered. The report includes a market projection for 2026 and market shares for key players. The report segments the market for autoimmune disease diagnostics based on technology, gender, indications and geography. Based on technology, the market is segmented into indirect immunofluorescence (IIF), enzyme-linked immunosorbent assay (ELISA), ImmunoBlot, multiplex immunoassays and others. Based on indications, the market is segmented into type 1 diabetes, rheumatoid arthritis (RA), psoriasis/psoriatic arthritis, multiple sclerosis, inflammatory bowel disease, systemic lupus erythematosus (SLE), and others (pernicious anemia, celiac disease, autoimmune vasculitis, myasthenia gravis, Hashimoto's thyroiditis, Sjogren's syndrome, Graves' disease, Addison's disease, etc.). Based on gender, the market is segmented into males and females. By geography, the market has been segmented into North America, Europe, the Asia-Pacific and the Rest of the World. A detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, the Gulf Cooperation Council countries and South Africa will be covered in the regional segments. For market estimates, data will be provided for 2020 as the base year, with estimates for 2021 and forecast values for 2026. Report Includes An overview of the global market for autoimmune disease diagnostics Estimation of the market size and analyses of the global market trends, with data from 2019, 2020 estimates for 2021 with a projection of CAGR through 2026 Market share analysis of autoimmune disease diagnostics based on technology, indication, region and gender and identification of new opportunities, challenges, and technological changes within the industry A detailed description of autoimmune disorder & therapies, and causes such as intrinsic factors, environmental factors, and lifestyle factors, and insights into a new diagnostic pathway for autoimmune and inflammatory disorders Discussion on the role of bioinformatics and biomarkers on autoimmune disorder therapies and information on standardization of test results Coverage of new product launches in the therapeutics for autoimmune diseases and performance methods in the detection of autoimmune antibodies Detailed analysis of the current market trends, market forecast, and discussion of technological, and regulatory elements that are affecting the future marketplace Key Topics Covered: Report Highlights Autoimmune Disorders and Therapies Standardization of Test Results Shortage of Skilled Technicians for Performing Diagnostic Assays Emerging Technologies in Autoimmune Diagnostics Bioinformatics Rise in the Geriatric Population Rising Awareness of Autoimmune Diseases New Diagnostic Pathway for Autoimmune and Inflammatory Disorders Market Restraints High Cost of Autoimmune Disease Diagnostics Market Opportunities

immco Diagnostics Frequently Asked Questions (FAQ)

  • Where is immco Diagnostics's headquarters?

    immco Diagnostics's headquarters is located at 10 Earhart Drive, Buffalo.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.